ADAM17 and diabetes mellitus: In summary, ADAM17 knockout reduced diabetes-induced collagen synthesis and ameliorated cardiac remodeling through the inhibition of RAAS overactivation when combined with eplerenone treatment, which reducing TGF-β1/Smad3 pathway activation-mediated CMT.